Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Mechanisms in endocrinology. Role of emotional stress in the pathophysiology of Graves' disease.

Falgarone G, Heshmati HM, Cohen R, Reach G.

Eur J Endocrinol. 2012 Dec 10;168(1):R13-8. doi: 10.1530/EJE-12-0539. Review.

2.

[Anomalies of cellular immunity in Graves' disease treated by synthetic antithyroid drugs: effects on prognosis].

Allannic H, Genetet N, Edan G, Merdrignac G, Simon M, Genetet B.

Pathol Biol (Paris). 1987 Dec;35(10):1333-8. French.

PMID:
2449649
3.

The pathogenesis of Graves' disease.

Gossage AA, Munro DS.

Clin Endocrinol Metab. 1985 May;14(2):299-330.

PMID:
2866051
4.

Understanding the immunology of Graves' ophthalmopathy. Is it an autoimmune disease?

Bahn RS.

Endocrinol Metab Clin North Am. 2000 Jun;29(2):287-96, vi. Review.

PMID:
10874530
5.

Chronic recurrent stress due to panic disorder does not precipitate Graves' disease.

Chiovato L, Marinò M, Perugi G, Fiore E, Montanelli L, Lapi P, Cavaliere R, Ciampi M, Patronelli A, Placidi G, Placidi GF, Cassano GB, Pinchera A.

J Endocrinol Invest. 1998 Dec;21(11):758-64.

PMID:
9972676
6.

Reduction in the suppressor-inducer T cell subset and increase in the helper T cell subset in thyroid tissue from patients with Graves' disease.

Ishikawa N, Eguchi K, Otsubo T, Ueki Y, Fukuda T, Tezuka H, Matsunaga M, Kawabe Y, Shimomura C, Izumi M, et al.

J Clin Endocrinol Metab. 1987 Jul;65(1):17-23.

PMID:
2953751
7.

The decrease in non-specific suppressor T lymphocytes in female hyperthyroid Graves' disease is secondary to the hyperthyroidism.

Gerstein HC, Rastogi B, Iwatani Y, Iitaka M, Row VV, Volpé R.

Clin Invest Med. 1987 Jul;10(4):337-44.

PMID:
2888555
8.

Altered balance of immunoregulatory T lymphocyte subsets in autoimmune thyroid diseases.

Misaki T, Konishi J, Iida Y, Endo K, Torizuka K.

Acta Endocrinol (Copenh). 1984 Feb;105(2):200-4.

PMID:
6229968
9.
10.

Intrathyroidal accumulation of T cell phenotypes in autoimmune thyroid disease.

Martin A, Goldsmith NK, Friedman EW, Schwartz AE, Davies TF, Roman SH.

Autoimmunity. 1990;6(4):269-81.

PMID:
1716476
11.

Binding of immunoglobulin-G from patients with thyroid autoimmune disease to normal T lymphocytes.

Pacini F, Sridama V, Pressendo J, DeGroot LJ, Medof ME.

Clin Endocrinol (Oxf). 1983 Jul;19(1):29-37.

PMID:
6225570
12.

[Immunologic analysis of Graves' ophthalmopathy and ophthalmic Graves' disease].

Liao ZQ.

Zhonghua Yan Ke Za Zhi. 1990 May;26(3):162-4. Chinese.

PMID:
2144488
13.

[Studies on the suppressor T cell function in patients with autoimmune thyroid diseases].

Matsui J.

Nihon Naibunpi Gakkai Zasshi. 1984 Aug 20;60(8):925-38. Japanese.

PMID:
6096180
14.

The clinical immunology of Graves' ophthalmopathy.

Sergott RC, Felberg NT, Savino PJ, Blizzard JJ, Schatz NJ.

Ophthalmology. 1981 Jun;88(6):484-7.

PMID:
6973736
15.

Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves' disease.

Tötterman TH, Karlsson FA, Bengtsson M, Mendel-Hartvig I.

N Engl J Med. 1987 Jan 1;316(1):15-22.

PMID:
2946953
17.

Increased serum concentration of interleukin-5 in patients with Graves' disease and Hashimoto's thyroiditis.

Hidaka Y, Okumura M, Shimaoka Y, Takeoka K, Tada H, Amino N.

Thyroid. 1998 Mar;8(3):235-9.

PMID:
9545110
18.

[Thyroid-associated ophthalmopathy: physiopathology, endocrine status].

Teissier MP, Lopez S.

J Fr Ophtalmol. 2004 Sep;27(7):806-9. Review. French.

19.

Increase of peripheral B lymphocytes in Graves' disease.

Mori H, Amino N, Iwatani Y, Kabutomori O, Asari S, Motoi S, Miyai K, Kumahara Y.

Clin Exp Immunol. 1980 Oct;42(1):33-40.

20.

Pathophysiology of Graves' disease.

Pittman CS, Menefee JK.

Hosp Pract (Off Ed). 1987 May 15;22(5):147-57, 162-4. No abstract available.

PMID:
3106370

Supplemental Content

Support Center